Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32

• Main Authors: Kang Wu (Author), Jun Zeng (Author), Xulian Shi (Author), Jiajia Xie (Author), Yuqing Li (Author), Haoxiang Zheng (Author), Guoyu Peng (Author), Guanghui Zhu (Author), Dongdong Tang (Author), Song Wu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bladder cancer is a highly metastatic tumor and one of the most common malignancies originating in the urinary tract. Despite the efficacy of immune checkpoints, including programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), the effect of immunotherapy for bladder...